Progression-free survival of GB patients and overall survival of adult glioma patients with high SPRY4 levels were reduced in our R2 genomics analysis, whereas other studies revealed that high expression of SPRY4 is associated with better prognosis for GB patients [123]. This evidence concerns the gene SPRY4 and central nervous system cancer.